P. Braun

发表

HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge

H. Walter, R. Kaiser, K. Korn, 2012, Intervirology.

Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.

F. Wiesmann, P. Braun, 2007, European journal of medical research.

Performance of Genotypic Coreceptor Measurement Using Geno2pheno[coreceptor] in B- and non-B HIV Subtypes in a Large Cohort of Therapy-experienced Patients in Germany

Thomas Lengauer, H. Walter, R. Kaiser, 2009 .

Determination of HIV-1 co-receptor usage in German patients – comparison of genotypic methods with the TROFILE® phenotypic assay

H. Walter, R. Kaiser, T. Berg, 2008 .

A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay.

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment

A. Berger, C. Sarrazin, H. Wedemeyer, 2015, Medical Microbiology and Immunology.

Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference Assay

R. Kaiser, M. Däumer, E. Wolf, 2018, Journal of Clinical Microbiology.

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

H. Walter, R. Kaiser, T. Berg, 2011, AIDS research and therapy.

Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine

F. Wiesmann, P. Braun, R. Ehret, 2007, Clinical chemistry and laboratory medicine.

Switch to Efavirenz in a Protease Inhibitor-Containing Regimen

P. Braun, K. Stürner, H. Knechten, 2001, HIV clinical trials.

Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia

A. Berger, F. Wiesmann, P. Braun, 2013, Medical Microbiology and Immunology.

Multicenter clinical evaluation of alinity m HCV assay performance.

M. Obermeier, P. Braun, R. Ehret, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A European multicenter study on the analytical performance of the VERIS HBV assay.

A. Lombardi, H. Fleury, J. Izopet, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia

A. Berger, F. Wiesmann, P. Braun, 2012, Medical Microbiology and Immunology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains

Thomas Lengauer, Joachim Selbig, Niko Beerenwinkel, 2005 .

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Improved molecular laboratory productivity by consolidation of testing on the new random-access analyzer Alinity m

Martin Obermeier, Monia Pacenti, Robert Ehret, 2020 .

Multicenter clinical evaluation of alinity m HBV assay performance.

M. Obermeier, P. Braun, R. Ehret, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Significance of HCV RNA monitoring in the era of new potent therapies

F. Wiesmann, P. Braun, 2016, Expert review of anti-infective therapy.

Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors

R. Kaiser, A. Berger, C. Sarrazin, 2014, Medical Microbiology and Immunology.

Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment

A. Berger, C. Sarrazin, H. Wedemeyer, 2015, Medical Microbiology and Immunology.

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.

K. Metzner, H. Walter, R. Kaiser, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay.

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

European Multicenter Study on Analytical Performance of Veris HIV-1 Assay

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of Clinical Microbiology.

Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens

F. Wiesmann, P. Braun, H. Knechten, 2014, Journal of the International AIDS Society.

A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit.

A. Lombardi, H. Fleury, J. Izopet, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Multicenter clinical comparative evaluation of Alinity m HIV-1 assay performance.

M. Obermeier, P. Braun, R. Ehret, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay

Jordi Vila, Patrick Braun, Rafael Delgado, 2017, Journal of Clinical Microbiology.

Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition

B. Schmidt, H. Walter, R. Kaiser, 2011, Journal of acquired immune deficiency syndromes.

Differences of nine drug resistance interpretation systems in predicting short-term therapy outcomes of treatment-experienced HIV-1 infected patients: a retrospective observational cohort study.

B. Schmidt, H. Walter, K. Korn, 2007, European journal of medical research.